Quick Andrew
Known title: Chief Technology OfficerCIK: 0001817682
Associated companies
Transaction History
| RCEL | ▲ Buy | Grant | 35,950 | — | 7/1/2022 | View on chart |
| RCEL | ▲ Buy | Grant | 10,500 | — | 7/6/2021 | View on chart |
| RCEL | ▲ Buy | Grant | 35,950 | — | 7/1/2022 | View on chart |
| RCEL | ▲ Buy | Grant | 10,500 | — | 7/6/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
RCEL Gains Fair Value Lift After PermeaDerm Data and Q2 Beat
PermeaDerm data and a Q2 earnings beat lifted RCEL’s fair value. The news gave the stock a positive momentum boost. The lift comes as the company reports stronger‑than‑expected results and promising data from its PermeaDerm platform. The move is a short‑term reaction to the earnings beat and data release.
RCEL Gains Fair Value Lift After PermeaDerm Data and Q2 Beat. PermeaDerm data and a Q2 earnings beat lifted RCEL’s fair value. The news gave the stock a positive momentum boost. The lift comes as the company reports stronger‑than‑expected results and promising data from its PermeaDerm platform. The move is a short‑term reaction to the earnings beat and data release.